Salta al contenuto
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avanzata
  • Systemic review and economic e...
  • Citazione
  • Invia SMS
  • Invia email
  • Stampa
  • Esporta il record
    • Esporta a RefWorks
    • Esporta a EndNoteWeb
    • Esporta a EndNote
  • PLink permanente
Systemic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease

Systemic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease

Dettagli Bibliografici
Autori principali: Clark, W, Raftery, J, Song, F, Barton, P, Cummins, C, Fry-Smith, A, Burls, A
Natura: Journal article
Lingua:English
Pubblicazione: 2003
  • Posseduto
  • Descrizione
  • Documenti analoghi
  • MARC21

Documenti analoghi

  • Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
    di: Clark, W, et al.
    Pubblicazione: (2003)
  • Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
    di: Clark, W, et al.
    Pubblicazione: (2003)
  • Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
    di: W. Clark, et al.
    Pubblicazione: (2003-01-01)
  • A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
    di: Chen, Y, et al.
    Pubblicazione: (2006)
  • A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    di: Chen, Y, et al.
    Pubblicazione: (2006)

Opzioni di ricerca

  • Ultime ricerche
  • Ricerca avanzata

Cerca

  • Scorri il catalogo
  • Scorri in ordine alfabetico
  • Esplora selezioni
  • Materiali riservati (per i corsi)
  • Nuovi documenti

Serve aiuto?

  • Suggerimenti per la ricerca
  • Chiedi al bibliotecario
  • FAQ